/
/
/

IOL Chemicals And Pharmaceuticals Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
--2%12%
--0%36%
21%12%29%77%
9%9%8%8%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
IOLCP
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,849.9₹447476 Cr3712.0762.82₹11479 Cr
9,602₹254764 Cr87.134.04128.41₹2568 Cr
4,928.5₹189423 Cr86.8516.7297.06₹2163 Cr
1,180.3₹116658 Cr25.859.4262.53₹5040 Cr
1,399₹111484 Cr33.089.7757.87₹3879 Cr
2,026.2₹109943 Cr100.556.829.25₹889 Cr
2,500₹101712 Cr49.7913.7571.08₹1913 Cr
1,200.4₹101005 Cr31.355.3263.99₹4196 Cr
1,716₹99253 Cr26.7317.9596.84₹3505 Cr
2,100.7₹96031 Cr17.3730.95154.35₹5333 Cr
203.22₹6064 Cr36.072.198.51₹138 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022
—————
₹59 Cr₹59 Cr₹59 Cr₹59 Cr₹59 Cr
₹1740 Cr₹1629 Cr₹1553 Cr₹1449 Cr₹1334 Cr
₹1740 Cr₹1629 Cr₹1553 Cr₹1449 Cr₹1334 Cr
₹1799 Cr₹1688 Cr₹1612 Cr₹1508 Cr₹1392 Cr
₹85 Cr₹78 Cr₹66 Cr₹56 Cr₹53 Cr
₹2 Cr₹0₹4 L₹14 L₹43 L
₹11 Cr₹7 Cr₹7 Cr₹2 Cr₹3 Cr
₹98 Cr₹85 Cr₹73 Cr₹58 Cr₹57 Cr
—————
₹483 Cr₹428 Cr₹469 Cr₹314 Cr₹409 Cr
₹70 Cr₹63 Cr₹55 Cr₹54 Cr₹54 Cr
₹132 Cr₹117 Cr₹33 Cr₹80 Cr₹43 Cr
₹49 Cr₹31 Cr₹40 Cr₹54 Cr₹69 Cr
₹733 Cr₹639 Cr₹597 Cr₹503 Cr₹575 Cr
₹2630 Cr₹2411 Cr₹2282 Cr₹2068 Cr₹2024 Cr
₹6 Cr₹6 Cr₹6 Cr₹5 Cr₹18 L
₹132 Cr₹117 Cr₹33 Cr₹80 Cr₹43 Cr
—————
₹1632 Cr₹1544 Cr₹1236 Cr₹995 Cr₹762 Cr
₹451 Cr₹374 Cr₹303 Cr₹243 Cr₹201 Cr
₹1182 Cr₹1171 Cr₹933 Cr₹752 Cr₹561 Cr
₹94 Cr₹21 Cr₹100 Cr₹81 Cr₹102 Cr
₹17 Cr₹17 Cr₹17 Cr₹17 Cr₹0
₹17 Cr₹17 Cr₹17 Cr₹17 Cr₹0
₹20 Cr₹12 Cr₹24 Cr₹10 Cr₹11 Cr
₹45 Cr₹9 Cr₹50 Cr₹233 Cr₹205 Cr
₹1359 Cr₹1231 Cr₹1125 Cr₹1102 Cr₹881 Cr
—————
₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr
₹371 Cr₹361 Cr₹425 Cr₹326 Cr₹410 Cr
₹603 Cr₹514 Cr₹471 Cr₹505 Cr₹470 Cr
₹198 Cr₹208 Cr₹143 Cr₹22 Cr₹140 Cr
₹30 Cr₹27 Cr₹25 Cr₹30 Cr₹31 Cr
₹65 Cr₹67 Cr₹90 Cr₹82 Cr₹90 Cr
₹1271 Cr₹1180 Cr₹1157 Cr₹967 Cr₹1143 Cr
₹537 Cr₹541 Cr₹560 Cr₹464 Cr₹567 Cr
₹2630 Cr₹2411 Cr₹2282 Cr₹2068 Cr₹2024 Cr
₹61₹57₹274₹257₹237
₹61₹57₹55₹257₹237

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022
₹184 Cr₹138 Cr₹182 Cr₹189 Cr₹225 Cr
₹85 Cr₹80 Cr₹60 Cr₹44 Cr₹33 Cr
-₹17 Cr-₹21 Cr₹90 Cr-₹64 Cr-₹102 Cr
₹252 Cr₹197 Cr₹332 Cr₹169 Cr₹156 Cr
₹214 Cr₹179 Cr₹290 Cr₹122 Cr₹93 Cr
-₹198 Cr-₹154 Cr-₹191 Cr-₹120 Cr-₹121 Cr
-₹29 Cr₹46 Cr-₹93 Cr-₹4 Cr-₹2 Cr
-₹13 Cr₹70 Cr₹6 Cr-₹2 Cr-₹29 Cr
₹78 Cr₹8 Cr₹1 Cr₹3 Cr₹32 Cr
₹65 Cr₹78 Cr₹8 Cr₹1 Cr₹3 Cr

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)205.00
Volume (₹)35.84 L
High (₹)212.99
Upper Circuit247.92
Low (₹)201.32
Lower Circuit165.28
Prev Close206.60
52W High (₹)219.04
Price203.22
52W Low (₹)67.19

Share Market Cap & Key Ratios Overview

M.Cap (₹)6064.28 Cr
Div. Yield (%)0.10
PE Ratio36.07
Debt to Equity0.07
Price to Book1.19
Book Value61.27
EPS (TTM)5.73
Face Value2.00
ROE (%)7.90

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
IOLCPNSE
LTP
1W Low
1W High
Market cap (₹)
1849.9+12.6 (0.69%)
1832.20
1891.50
4,47,476Cr
9602+227 (2.42%)
9312.50
9740
2,54,764Cr
4928.5+88.5 (1.83%)
4848.50
5010
1,89,423Cr
1180.3+20.3 (1.75%)
1152.10
1190.60
1,16,658Cr
1399+4.5 (0.32%)
1364.50
1419
1,11,484Cr
2026.2+72.2 (3.69%)
1963.80
2055.30
1,09,943Cr
2500+199.3 (8.66%)
2303
2504.30
1,01,712Cr
1200.4+15.4 (1.30%)
1185
1222
1,01,005Cr
1716-18 (-1.04%)
1689.30
1740
99,253Cr
2100.7+17.7 (0.85%)
2080
2135
96,031Cr
203.22+0.07 (0.03%)
193.46
212.99
6,064Cr

IOL Chemicals And Pharmaceuticals Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹111.67Cr; with other income of ₹8.18Cr, profit before interest and tax came to ₹90.33Cr. Interest expense was ₹3.64Cr; PBT before exceptional items stood at ₹86.69Cr. Cost mix (full year): raw materials ₹1505.63Cr; employee cost ₹248.26Cr; depreciation ₹21.34Cr; other expenses ₹652.77Cr. Basis: consolidated annual results.

IOL Chemicals And Pharmaceuticals Ltd Quaterly Results Key Takeaways

IOL Chemicals And Pharmaceuticals Ltd reported ₹756.26Cr total income from operations in Jun 2026, softer than ₹619.45Cr in Mar 2026 but higher than ₹551.69Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹111.67Cr; with other income of ₹8.18Cr, profit before interest and tax came to ₹90.33Cr. Interest expense was ₹3.64Cr, taking profit before tax to ₹86.69Cr. After tax of ₹22.29Cr, profit after tax stood at ₹64.4Cr (vs ₹53.16Cr in Mar 2026 and ₹33.93Cr in Jun 2025).